keyword
https://read.qxmd.com/read/38631706/tumor-targeted-therapy-with-braf-inhibitor-recruits-activated-dendritic-cells-to-promote-tumor-immunity-in-melanoma
#1
JOURNAL ARTICLE
Florian Hornsteiner, Janine Vierthaler, Helen Strandt, Antonia Resag, Zhe Fu, Markus Ausserhofer, Christoph H Tripp, Sophie Dieckmann, Markus Kanduth, Kathryn Farrand, Sarah Bregar, Niloofar Nemati, Natascha Hermann-Kleiter, Athanasios Seretis, Sudhir Morla, David Mullins, Francesca Finotello, Zlatko Trajanoski, Guido Wollmann, Franca Ronchese, Marc Schmitz, Ian F Hermans, Patrizia Stoitzner
BACKGROUND: Tumor-targeted therapy causes impressive tumor regression, but the emergence of resistance limits long-term survival benefits in patients. Little information is available on the role of the myeloid cell network, especially dendritic cells (DC) during tumor-targeted therapy. METHODS: Here, we investigated therapy-mediated immunological alterations in the tumor microenvironment (TME) and tumor-draining lymph nodes (LN) in the D4M.3A preclinical melanoma mouse model (harboring the V-Raf murine sarcoma viral oncogene homolog B (BRAF)V600E mutation) by using high-dimensional multicolor flow cytometry in combination with multiplex immunohistochemistry...
April 17, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38625118/monophosphoryl-lipid-a-based-adjuvant-to-promote-the-immunogenicity-of-multivalent-meningococcal-polysaccharide-conjugate-vaccines
#2
JOURNAL ARTICLE
Kishore R Alugupalli
Activation of the adaptive immune system requires the engagement of costimulatory pathways in addition to B and T cell Ag receptor signaling, and adjuvants play a central role in this process. Many Gram-negative bacterial polysaccharide vaccines, including the tetravalent meningococcal conjugate vaccines (MCV4) and typhoid Vi polysaccharide vaccines, do not incorporate adjuvants. The immunogenicity of typhoid vaccines is due to the presence of associated TLR4 ligands in these vaccines. Because the immunogenicity of MCV4 is poor and requires boosters, I hypothesized that TLR4 ligands are absent in MCV4 and that incorporation of a TLR4 ligand-based adjuvant would improve their immunogenicity...
April 1, 2024: ImmunoHorizons
https://read.qxmd.com/read/38612376/a-prospective-observational-study-analyzing-the-diagnostic-value-of-hepcidin-25-for-anemia-in-patients-with-inflammatory-bowel-diseases
#3
JOURNAL ARTICLE
Stanko Petrović, Dino Tarabar, Danica Ćujić, Dusica Stamenkovic, Marijana Petrović, Nemanja Rančić, Vesna Subota, Nenad Perišić, Mihailo Bezmarević
Iron deficiency (IDA) and chronic disease (ACD) anemia are complications of inflammatory bowel diseases (IBDs). Therapeutic modalities in remission and active IBD depend on the type of anemia. This study evaluated the link between hepcidin-25, proinflammatory cytokines, and platelet activation markers as biomarkers of anemia and inflammation in active IBD and remission. This prospective observational study included 62 patients with IBD (49 with ulcerative colitis and 13 with Crohn's) and anemia. Patients were divided into Group I (no or minimal endoscopic signs of disease activity and IDA), Group II (moderate and major endoscopic signs of disease activity and mild ACD), and Control group (10 patients with IBD in remission, without anemia)...
March 22, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38594504/bone-marrow-stromal-cells-dictate-lanosterol-biosynthesis-and-ferroptosis-of-multiple-myeloma
#4
JOURNAL ARTICLE
Hongmei Jiang, Lijuan Wang, Qiguo Zhang, Sheng Wang, Linchuang Jia, Hao Cheng, Jingya Wang, Xin Li, Ying Xie, Yixuan Wang, Meilin Hu, Jing Guo, Qian Li, Ziyi Peng, Mengqi Wang, Yangyang Xie, Tiantian Li, Yafei Wang, Bill D Geng, Sundararaman Swaminathan, P Leif Bergsagel, Zhiqiang Liu
Ferroptosis has been demonstrated a promising way to counteract chemoresistance of multiple myeloma (MM), however, roles and mechanism of bone marrow stromal cells (BMSCs) in regulating ferroptosis of MM cells remain elusive. Here, we uncovered that MM cells were more susceptible to ferroptotic induction under the interaction of BMSCs using in vitro and in vivo models. Mechanistically, BMSCs elevated the iron level in MM cells, thereby activating the steroid biosynthesis pathway, especially the production of lanosterol, a major source of reactive oxygen species (ROS) in MM cells...
April 9, 2024: Oncogene
https://read.qxmd.com/read/38593939/assessing-the-causal-relationship-between-immune-cell-traits-and-depression-by-mendelian-randomization-analysis
#5
JOURNAL ARTICLE
Hua Xue, Jiajia Chen, Wenhui Fan
BACKGROUND: Observational studies suggested that immune system disorder is associated with depression. However, the causal association has not been fully elucidated. Thus, we aim to assess the causality of the associations of immune cell profiles with risk of depression through Mendelian randomization analysis. METHODS: We extracted genetic variances of immune cell traits from a large publicly available genome-wide association study (GWAS) involving 3757 participants and depression from a GWAS containing 246,363 cases and 561,190 controls of European ancestry...
April 7, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38587548/a-novel-hemizygous-cd40l-mutation-of-x-linked-hyper-igm-syndromes-and-compound-heterozygous-dock8-mutations-of-hyper-ige-syndromes-in-two-chinese-families
#6
JOURNAL ARTICLE
Mingzhen Guo, Yuanxuan Ma, Kangxi Cai, Xiuxiang Liu, Wenmiao Liu, Fengqi Wang, Niyan Qu, Shiguo Liu
X-linked hyper-immunoglobulin M (X-HIGM) syndrome and autosomal recessive hyper-immunoglobulin E syndrome (HIES) are rare inborn errors of immunity characterized by recurrent infections due to immune system impairment. In this study, we identified a novel hemizygous CD40 ligand (CD40L) mutation and compound heterozygous dedicator of cytokinesis-8 (DOCK8) mutations in two Han Chinese families with X-HIGM and HIES, respectively. We aimed to investigate the association between their genotypes and phenotypes. Genomic DNA was extracted from peripheral blood samples obtained from the families...
April 8, 2024: Immunogenetics
https://read.qxmd.com/read/38582994/relationship-between-phenotypic-changes-of-dendritic-cell-subsets-and-the-onset-of-plateau-phase-during-intermittent-interferon-therapy-in-patients-with-chb
#7
JOURNAL ARTICLE
Liu Yang, Shi Yu Wang, Ting Ting Jiang, Wen Deng, Min Chang, Shu Ling Wu, Wei Hua Cao, Yao Lu, Ge Shen, Ru Yu Liu, Yuan Jiao Gao, Meng Jiao Xu, Lei Ping Hu, Lu Zhang, Yao Xie, Ming Hui Li
OBJECTIVE: This study aimed to evaluate whether the onset of the plateau phase of slow hepatitis B surface antigen decline in patients with chronic hepatitis B treated with intermittent interferon therapy is related to the frequency of dendritic cell subsets and expression of the costimulatory molecules CD40, CD80, CD83, and CD86. METHOD: This was a cross-sectional study in which patients were divided into a natural history group (namely NH group), a long-term oral nucleoside analogs treatment group (namely NA group), and a plateau-arriving group (namely P group)...
March 20, 2024: Biomedical and Environmental Sciences: BES
https://read.qxmd.com/read/38581334/the-influence-of-cd40-cd40l-mmp2-mmp9-on-uterine-artery-blood-flow-and-their-expression-in-recurrent-miscarriage
#8
JOURNAL ARTICLE
Huirong Li, Liang Ding, Jian Ding, Fudan Huang
OBJECTIVE: This study aims to investigate the expression levels of soluble CD40L (sCD40L), matrix metalloproteinase 2 (MMP2), and matrix metalloproteinase 9 (MMP9) in the serum of patients experiencing recurrent abortion and their impact on uterine artery blood flow. METHODS: A cohort of 200 patients with recurrent abortion was selected for this investigation. The levels of sCD40L, MMP2, and MMP9 in serum were assessed using ELISA, while ultrasound was employed to measure the pulsatility index (PI) and resistance index (RI) in uterine artery blood flow...
April 5, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38579073/co-stimulators-cd40-cd40l-a-potential-immune-therapy-target-for-atherosclerosis-a-review
#9
JOURNAL ARTICLE
Simeng Tian, Yufei Wang, Jie Wan, Mao Yang, Zhenkun Fu
The interaction between CD40 and CD40 ligand (CD40L) a crucial co-stimulatory signal for activating adaptive immune cells, has a noteworthy role in atherosclerosis. It is well-known that atherosclerosis is linked to immune inflammation in blood vessels. In atherosclerotic lesions, there is a multitude of proinflammatory cytokines, adhesion molecules, and collagen, as well as smooth muscle cells, macrophages, and T lymphocytes, particularly the binding of CD40 and CD40L. Therefore, research on inhibiting the CD40-CD40L system to prevent atherosclerosis has been ongoing for more than 30 years...
April 5, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38579020/bilateral-slipped-capital-femoral-epiphysis-in-a-young-girl-treated-with-chemotherapy-a-case-report
#10
JOURNAL ARTICLE
J H J van Erp, J S Kuperus, J E J Bekkers, M C Kruyt
CASE: A 1-year-old girl was treated with chemotherapy and hematopoietic stem cell transplantation because of CD40 ligand deficiency. Four years later, she presented with pain in her right leg, diagnosed as atypical acute slipped capital femoral epiphysis, without a clear cause, besides chemotherapy possibly. She was treated with fixation of the epiphysis with a cannulated screw. Two years later, the same diagnosis was made for the left hip and the same surgery was applied. After the 2-year follow-up, clinical outcomes were good...
April 1, 2024: JBJS Case Connector
https://read.qxmd.com/read/38578522/bariatric-surgery-improves-serum-cd40l-levels-as-a-predictor-of-cardiovascular-risk-systematic-review-and-meta-analysis
#11
REVIEW
Tannaz Jamialahamdi, Ali H Eid, Ninh T Nguyen, Kishore M Gadde, Vasily N Sukhorukov, Wael Almahmeed, Matthew Kroh, Amirhossein Sahebkar
CD40 and its ligand have been recently implicated in the pathogenesis of cardiovascular disease (CVD). This meta-analysis examined the effect of bariatric surgery in reducing circulating CD40L levels. A systematic review was performed using Embase, Google Scholar, PubMed, Scopus, and Web of Science. The meta-analysis was provided by Comprehensive Meta-Analysis (CMA) V4 software. The overall effect size was detected by a random-effects meta-analysis and the leave-one-out approach. Random-effects meta-analysis of 7 studies including 191 subjects showed a significant reduction in CD40L after bariatric surgery (standardized mean difference (SMD), - 0...
April 5, 2024: Obesity Surgery
https://read.qxmd.com/read/38574931/fermentation-enrichment-structural-characterization-and-immunostimulatory-effects-of-%C3%AE-glucan-from-quinoa
#12
JOURNAL ARTICLE
Nan Ma, Rong Li, SangGuan You, Dong-Jie Zhang
We developed an efficient mixed-strain co-fermentation method to increase the yield of quinoa β-glucan (Q+). Using a 1:1 mass ratio of highly active dry yeast and Streptococcus thermophilus, solid-to-liquid ratio of 1:12 (g/mL), inoculum size of 3.8 % (mass fraction), fermentation at 32 °C for 27 h, we achieved the highest β-glucan yield of (11.13 ± 0.80)%, representing remarkable 100.18 % increase in yield compared to quinoa β-glucan(Q-) extracted using hot water...
April 2, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38564451/efficacy-and-safety-of-bleselumab-in-preventing-the-recurrence-of-primary-focal-segmental-glomerulosclerosis-in-kidney-transplant-recipients-a-phase-2a-randomized-multicenter-study
#13
JOURNAL ARTICLE
Jun Shoji, William C Goggins, Jason R Wellen, Patrick N Cunningham, Olwyn Johnston, Shirley S Chang, Kim Solez, Vicki Santos, Tami J Larson, Masahiro Takeuchi, Xuegong Wang
BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is a common cause of end-stage kidney disease and frequently recurs after kidney transplantation. Recurrent FSGS (rFSGS) is associated with poor allograft and patient outcomes. Bleselumab, a fully human immunoglobulin G4 anti-CD40 antagonistic monoclonal antibody, disrupts CD40-related processes in FSGS, potentially preventing rFSGS. METHODS: A phase 2a, randomized, multicenter, open-label study of adult recipients (aged ≥18 y) of a living or deceased donor kidney transplant with a history of biopsy-proven primary FSGS...
April 1, 2024: Transplantation
https://read.qxmd.com/read/38562963/modulatory-actions-of-echinococcus-granulosus-antigen-b-on-macrophage-inflammatory-activation
#14
JOURNAL ARTICLE
Ana Maite Folle, Sofía Lagos Magallanes, Martín Fló, Romina Alvez-Rosado, Federico Carrión, Cecilia Vallejo, David Watson, Josep Julve, Gualberto González-Sapienza, Otto Pristch, Andrés González-Techera, Ana María Ferreira
Cestodes use own lipid-binding proteins to capture and transport hydrophobic ligands, including lipids that they cannot synthesise as fatty acids and cholesterol. In E. granulosus s.l., one of these lipoproteins is antigen B (EgAgB), codified by a multigenic and polymorphic family that gives rise to five gene products (EgAgB8/1-5 subunits) assembled as a 230 kDa macromolecule. EgAgB has a diagnostic value for cystic echinococcosis, but its putative role in the immunobiology of this infection is still poorly understood...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38561566/immunomodulatory-potential-of-rapamycin-loaded-mesoporous-silica-nanoparticles-pore-size-dependent-drug-loading-release-and-in-vitro-cellular-responses
#15
JOURNAL ARTICLE
Ana M Pérez-Moreno, Carlos J Aranda, María José Torres, Cristobalina Mayorga, Juan L Paris
Rapamycin is a potent immunosuppressive drug that has been recently proposed for a wide range of applications beyond its current clinical use. For some of these proposed applications, encapsulation in nanoparticles is key to ensure therapeutic efficacy and safety. In this work, we evaluate the effect of pore size on mesoporous silica nanoparticles (MSN) as rapamycin nanocarriers. The successful preparation of MSN with 4 different pore sizes was confirmed by dynamic light scattering, zeta potential, transmission electron microscopy and N2 adsorption...
April 1, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38559055/cd40-is-an-immune-checkpoint-regulator-that-potentiates-myocardial-inflammation-through-activation-and-expansion-of-ccr2-macrophages-and-cd8-t-cells
#16
Jesus Jimenez, Junedh Amrute, Pan Ma, Xiaoran Wang, Raymond Dai, Kory J Lavine
Novel immune checkpoint therapeutics including CD40 agonists have tremendous promise to elicit antitumor responses in patients resistant to current therapies. Conventional immune checkpoint inhibitors (PD-1/PD-L1, CTLA-4 antagonists) are associated with serious adverse cardiac events including life-threatening myocarditis. However, little is known regarding the potential for CD40 agonists to trigger myocardial inflammation or myocarditis. Here, we leveraged genetic mouse models, single cell sequencing, and cell depletion studies to demonstrate that an anti-CD40 agonist antibody reshapes the cardiac immune landscape through activation of CCR2 + macrophages and subsequent recruitment of effector memory CD8 T-cells...
March 16, 2024: bioRxiv
https://read.qxmd.com/read/38557165/exploratory-study-of-blood-biomarkers-in-patients-with-post-stroke-epilepsy
#17
JOURNAL ARTICLE
Laura Abraira, Samuel López-Maza, Manuel Quintana, Elena Fonseca, Manuel Toledo, Daniel Campos-Fernández, Sofía Lallana, Laia Grau-López, Jordi Ciurans, Marta Jiménez, Juan Luis Becerra, Alejandro Bustamante, Marta Rubiera, Anna Penalba, Joan Montaner, José Álvarez Sabin, Estevo Santamarina
INTRODUCTION: In addition to clinical factors, blood-based biomarkers can provide useful information on the risk of developing post-stroke epilepsy (PSE). Our aim was to identify serum biomarkers at stroke onset that could contribute to predicting patients at higher risk of PSE. PATIENTS AND METHODS: From a previous study in which 895 acute stroke patients were followed-up, 51 patients developed PSE. We selected 15 patients with PSE and 15 controls without epilepsy...
April 1, 2024: European Stroke Journal
https://read.qxmd.com/read/38554187/role-of-inflammatory-signaling-pathways-involving-the-cd40-cd40l-traf-cascade-in-diabetes-and-hypertension-insights-from-animal-and-human-studies
#18
JOURNAL ARTICLE
Lea Strohm, Andreas Daiber, Henning Ubbens, Roopesh Krishnankutty, Matthias Oelze, Marin Kuntic, Omar Hahad, Veronique Klein, Imo E Hoefer, Alex von Kriegsheim, Hartmut Kleinert, Dorothee Atzler, Philipp Lurz, Christian Weber, Philipp S Wild, Thomas Münzel, Christoph Knosalla, Esther Lutgens, Steffen Daub
CD40L-CD40-TRAF signaling plays a role in atherosclerosis progression and affects the pathogenesis of coronary heart disease (CHD). We tested the hypothesis that CD40L-CD40-TRAF signaling is a potential therapeutic target in hyperlipidemia, diabetes, and hypertension. In mouse models of hyperlipidemia plus diabetes (db/db mice) or hypertension (1 mg/kg/d angiotensin-II for 7 days), TRAF6 inhibitor treatment (2.5 mg/kg/d for 7 or 14 days) normalized markers of oxidative stress and inflammation...
March 30, 2024: Basic Research in Cardiology
https://read.qxmd.com/read/38553868/similar-immune-responses-to-alpha1-oleate-and-bacillus-calmette-gu%C3%A3-rin-treatment-in-patients-with-bladder-cancer
#19
JOURNAL ARTICLE
Shahram Ahmadi, Ines Ambite, Antonín Brisuda, Jaromír Háček, Farhan Haq, Samudra Sabari, Kamala Vanarsa, Chandra Mohan, Marek Babjuk, Catharina Svanborg
BACKGROUND: The molecular content of urine is defined by filtration in the kidneys and by local release from tissues lining the urinary tract. Pathological processes and different therapies change the molecular composition of urine and a variety of markers have been analyzed in patients with bladder cancer. The response to BCG immunotherapy and chemotherapy has been extensively studied and elevated urine concentrations of IL-1RA, IFN-α, IFN-γ TNF-α, and IL-17 have been associated with improved outcome...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38552961/differential-induction-of-donor-reactive-foxp3-treg-via-blockade-of-cd154-vs-cd40
#20
JOURNAL ARTICLE
Danya Liu, Hongmin Yao, Mandy L Ford
Recently published studies in both murine models and a meta-analysis of NHP renal transplant studies showed that anti-CD154 reagents conferred a significant survival advantage over CD40 blockers in both animal models and across multiple organs. Here we sought to compare the induction of donor-reactive Foxp3+ iTreg in mice treated with anti-CD154 vs. anti-CD40 mAb. Results indicated that while treatment with anti-CD154 resulted in a significant increase in the frequency of donor-reactive CD4+ Foxp3+ iTreg following transplantation, treatment with anti-CD40 or Cd40 deficiency failed to recapitulate this result...
March 27, 2024: American Journal of Transplantation
keyword
keyword
18833
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.